SCHEMBL24744356

SCHEMBL24744356

Oc1ccc(F)c(-c2nc(Nc3ccncc3)c3nccnc3n2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.77
PRKD3 O94806 1/20 0.77
PRKD1 Q15139 1/20 0.77
PRKD2 Q9BZL6 1/20 0.77
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
MAPK10 P53779 1/20 0.43
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ABCG2 Q9UNQ0 6/20 0.37
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALK Q9UM73 1/20 0.36
AURKA O14965 1/20 0.35
SYK P43405 1/20 0.35
MAP4K4 O95819 1/20 0.34
LMNA P02545 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128085 0.88 TGFBR1 (0.77) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL14344430 0.88 TGFBR1 (0.80) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL29381400 0.87 TGFBR1 (1.00) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL411646 0.87 TGFBR1 (1.00) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL29361383 0.87 TGFBR1 (1.00) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL14344351 0.84 TGFBR1 (0.74) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL14344357 0.83 TGFBR1 (0.72) TGFBR1PRKD3PRKD1PRKD2MEN1
SCHEMBL2126398 0.79 TGFBR1 (0.64) TGFBR1PRKD3PRKD1PRKD2FLT1
SCHEMBL14344415 0.76 TGFBR1 (0.62) TGFBR1PRKD3PRKD1PRKD2MEN1
SCHEMBL2128905 0.76 TGFBR1 (0.59) TGFBR1PRKD3PRKD1PRKD2FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11413286-B2 Producing astrocytes using small molecules CITY OF HOPE (US) 2022-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11413286-B2 Producing astrocytes using small molecules CHAT, GMFG, DCX TGFBR1 3711/4885PRKD3 1516/4885PRKD1 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.